Rebuilding Connections. Restoring Lives.
Neurotrope is discovering restorative therapeutics for patients with life-altering neurodegenerative diseases and development disorders.
We are a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders.
Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer’s Disease, Fragile X Syndrome and Niemann-Pick Type C.
Company Details
- Founded
- 2012
- Address
- 1185 Avenue Of The Americas, 3rd Floor,united States
- Phone
- 945-632-6630
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- neurotrope.com
- HQ
- New York, New York
Neurotrope Inc. Questions
Neurotrope Inc.'s helpline number is 945-632-6630
Neurotrope Inc.'s website is neurotrope.com
Neurotrope Inc.'s LinkedIn profile is https://www.linkedin.com/company/neurotrope
Neurotrope Inc.'s industry is
Pharmaceutical Manufacturing
Neurotrope Inc.'s top competitors are
Oligomerix, Inc,
Argenx,
Biogen,
Neuralstem, Inc.,
Mitsubishi Tanabe Pharma Corporation,
Ac Immune,
Evotec,
Celgene,
Axon Neuroscience,
Receptos, A Wholly-Owned Subsidiary Of Celgene.
Neurotrope Inc.'s categories are Pharmaceutical Manufacturing
Neurotrope Inc.'s founding year is 2012
